594 results on '"Gedde-Dahl T"'
Search Results
2. The CD34+ Cell Dose Matters in Hematopoietic Stem Cell Transplantation with Peripheral Blood Stem Cells from Sibling Donors
3. EBMT prospective observational study on allogeneic hematopoietic stem cell transplantation in T-prolymphocytic leukemia (T-PLL)
4. Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT
5. Safety and efficacy of the combination of pegylated interferon-α2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients
6. S238: MATCHED RELATED VERSUS UNRELATED VERSUS HAPLOIDENTICAL DONORS FOR ALLOGENEIC TRANSPLANTATION IN AML PATIENTS ACHIEVING FIRST COMPLETE REMISSION AFTER TWO INDUCTION COURSES: A STUDY FROM THE ALWP/EBMT
7. Outcome of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working Party
8. Addition of Anti-thymocyte Globulin in Allogeneic Stem Cell Transplantation With Peripheral Stem Cells From Matched Unrelated Donors Improves Graft-Versus-Host Disease and Relapse Free Survival
9. Total body irradiation plus fludarabine compared to busulfan plus fludarabine as 'reduced-toxicity conditioning' for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation in first complete remission: a study by the Acute Leukemia Working Party of the EBMT
10. Molecular status 36 months after TKI discontinuation in CML is highly predictive for subsequent loss of MMR—final report from AFTER-SKI
11. Impact of malignant stem cell burden on therapy outcome in newly diagnosed chronic myeloid leukemia patients
12. Ultra-short course sirolimus contributes to effective GVHD prophylaxis after reduced-intensity allogeneic hematopoietic cell transplantation
13. Post remission consolidation by autologous HCT for AML in CR1, negative implications for subsequent allogeneic HCT in CR2. A Study by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
14. A founder mutation for ichthyosis prematurity syndrome restricted to 76 kb by haplotype association
15. Erratum: Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT
16. Selecting and deselecting imatinib-resistant clones: observations made by longitudinal, quantitative monitoring of mutated BCR-ABL
17. HLA-DPB1 mismatch reduce relapse and improve survival in T-cell replete unrelated donor allogeneic stem cell transplantation
18. Congenital ichthyosis: mutations in ichthyin are associated with specific structural abnormalities in the granular layer of epidermis
19. Treatment outcome in adults with acute lymphoblastic leukemia: 50% long-term disease-free survival
20. Assignment of the locus for ichthyosis prematurity syndrome to chromosome 9q33.3–34.13
21. Activated prothrombin complex concentrate (FEIBA®) treatment during surgery in patients with inhibitors to FVIII/IX
22. Life-long Course and Molecular Characterization of the Original Dutch Family with Epidermolysis Bullosa Simplex with Muscular Dystrophy due to a Homozygous Novel Plectin Point Mutation
23. Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy
24. Generalized dystrophic epidermolysis bullosa: identification of a novel, homozygous glycine substitution, G2031S, in exon 73 of COL7A1 in monozygous triplets
25. The Impact of HLA-DPB1 Mismatch in T-Cell Replete Unrelated Donor Allogeneic Stem Cell Transplantation
26. On the genetics of hypodontia and microdontia: synergism or allelism of major genes in a family with six affected members
27. A pilot study of single nucleotide polymorphisms in the interleukin-6 receptor and their effects on pre- and post-transplant serum mediator level and outcome after allogeneic stem cell transplantation
28. "Gpt-EBS₁" Linkage Group: General Linkage Relations
29. Iron and meningococcal disease. S-ferritin, S-iron and S-total iron binding capacity in meningococcal disease patients and patient controls
30. Linkage Relations of the Phosphoglucomutase PGM₁ Locus in Man: Probable Linkage to Phenylthiocarbamid (PTC) Taster Locus
31. A Probable Crossing Over or Mutation in the MNSs Blood Group System
32. A Note on the PGM₁-PTC Linkage Relation
33. Genetics of the Pi Serum Types: Family Studies of the Inherited Variants of Serum Alpha₁-Antitrypsin
34. GPT – Epidermolysis Bullosa Simplex (EBS Ogna) Linkage in Man
35. Relapse risk score after allogeneic stem cell transplantation for MDS patients. An EBMT study from the MDS subcommittee of Chronic Malignancies Working Party (CMWP)
36. Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia
37. Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT
38. Prospective analysis of prognostic pre-transplant factors in MDS primarily treated by allogeneic hematopoietic stem cell transplantation: a study on behalf of the MDS subcommittee of the Chronic Malignancies Working Party of the EBMT
39. Role of allogeneic SCT in low risk MDS: A Retrospective Study on Behalf of the CMWP of the EBMT
40. Prospective analysis of prognostic pre-transplant factors in MDS primarily treated by allogeneic hematopoietic stem cell transplantation: a study on behalf of the MDS subcommittee of the Chronic Malignancies Working Party of the EBMT
41. Congenital Generalized lipodystrophy of Berardinelli-Seip: a study of 47 patients belonging to 9q34 and non-9q34 subgroups
42. Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia
43. The Kidd (JK) blood group locus assigned to chromosome 18 by close linkage to a DNA-RFLP
44. Generalized atrophic benign epidermolysis bullosa. Either 180-kd bullous pemphigoid antigen or laminin-5 deficiency
45. Improved progression free survival with bortezomib consolidation after high dose melphalan: results of a randomised phase III trial
46. Allogeneic hematopoietic cell transplantation in acute myeloid leukemia with normal karyotype and isolated Nucleophosmin-1 (NPM1) mutation: outcome strongly correlates with disease status
47. Genetic Studies of Apolipoprotein A-IV by Two-Dimensional Electrophoresis
48. Genetic Polymorphisms and Linkage Relations of Complement Factor C8
49. A Structural Locus for Coagulation Factor XIIIA (F13A) is Located Distal to HLA on the Short Arm of Chromosome 6 in Man
50. The ESD polymorphism: Further studies of the ESD2 and ESD5 allele products
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.